-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ClMjJh9H3YE37A4SkSoqV8X6WOEgo+mt++0jhmpWgJMLAcVVxE7rn09eJrZqZxUe nG7AgRQn2PwoAqfzsYx0bA== 0000897069-08-001273.txt : 20080812 0000897069-08-001273.hdr.sgml : 20080812 20080812170538 ACCESSION NUMBER: 0000897069-08-001273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080809 FILED AS OF DATE: 20080812 DATE AS OF CHANGE: 20080812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUSH JOHN J CENTRAL INDEX KEY: 0001323151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 081010446 BUSINESS ADDRESS: BUSINESS PHONE: 301-280-4689 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 cmw3679_ex.xml X0303 4 2008-08-09 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001323151 RUSH JOHN J TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP and Chief Medical Officer Common Stock 2008-08-09 4 A 0 10000 0 A 47426 D These shares of stock represent performance shares being issued to the reporting person based on the achievement of certain performance targets for the period beginning with the third quarter of 2007 and ending with the second quarter of 2008. These shares vest to the extent of 25% on August 9, 2008 and continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Includes (i) unvested restricted shares and fully vested shares which total 20,000 shares of stock from an initial grant of 20,000 shares of restricted stock and performance shares made on August 9, 2007; (ii) unvested restricted shares and fully vested shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock made on June 12, 2006; (iii) unvested restricted shares and fully vested shares which total 9,207 shares of stock from an initial grant of 10,000 shares of restricted stock made on April 11, 2006; and (iv) unvested restricted shares and fully vested shares which total 9,219 shares of stock from an initial grant of 10,000 shares of restricted stock made on April 4, 2005. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Teri L. Champ, Attorney-in-Fact 2008-08-12 -----END PRIVACY-ENHANCED MESSAGE-----